美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE"
符合检索条件的记录共79
8 页 当前第 3 页  首页 上一页 下一页 最后一页 返回检索页
21药品名称DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
申请号040444产品号003
活性成分AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE市场状态处方药
剂型或给药途径TABLET;ORAL规格5MG;5MG;5MG;5MG
治疗等效代码AB参比药物
批准日期2002/06/19申请机构COREPHARMA LLC
22药品名称DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
申请号040444产品号004
活性成分AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE市场状态处方药
剂型或给药途径TABLET;ORAL规格7.5MG;7.5MG;7.5MG;7.5MG
治疗等效代码AB参比药物
批准日期2002/06/19申请机构COREPHARMA LLC
23药品名称DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
申请号040444产品号005
活性成分AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE市场状态处方药
剂型或给药途径TABLET;ORAL规格1.875MG;1.875MG;1.875MG;1.875MG
治疗等效代码AB参比药物
批准日期2014/11/03申请机构COREPHARMA LLC
24药品名称DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
申请号040444产品号006
活性成分AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE市场状态处方药
剂型或给药途径TABLET;ORAL规格3.125MG;3.125MG;3.125MG;3.125MG
治疗等效代码AB参比药物
批准日期2014/11/03申请机构COREPHARMA LLC
25药品名称DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
申请号040444产品号007
活性成分AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE市场状态处方药
剂型或给药途径TABLET;ORAL规格3.75MG;3.75MG;3.75MG;3.75MG
治疗等效代码AB参比药物
批准日期2014/11/03申请机构COREPHARMA LLC
26药品名称DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
申请号040456产品号001
活性成分AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE市场状态处方药
剂型或给药途径TABLET;ORAL规格1.25MG;1.25MG;1.25MG;1.25MG
治疗等效代码AB参比药物
批准日期2003/05/06申请机构ACTAVIS ELIZABETH LLC
27药品名称DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
申请号040456产品号002
活性成分AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE市场状态处方药
剂型或给药途径TABLET;ORAL规格2.5MG;2.5MG;2.5MG;2.5MG
治疗等效代码AB参比药物
批准日期2003/05/06申请机构ACTAVIS ELIZABETH LLC
28药品名称DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
申请号040456产品号003
活性成分AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE市场状态处方药
剂型或给药途径TABLET;ORAL规格5MG;5MG;5MG;5MG
治疗等效代码AB参比药物
批准日期2003/05/06申请机构ACTAVIS ELIZABETH LLC
29药品名称DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
申请号040456产品号004
活性成分AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE市场状态处方药
剂型或给药途径TABLET;ORAL规格7.5MG;7.5MG;7.5MG;7.5MG
治疗等效代码AB参比药物
批准日期2003/05/06申请机构ACTAVIS ELIZABETH LLC
30药品名称DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
申请号040472产品号001
活性成分AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE市场状态停止上市
剂型或给药途径TABLET;ORAL规格1.25MG;1.25MG;1.25MG;1.25MG
治疗等效代码参比药物
批准日期2003/09/30申请机构TEVA PHARMACEUTICALS USA